US Map / Virginia
State VA

Clinical Trials in Virginia

Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.

Total Trials
250
Recruiting Now
250
← Back to US Map
Top Conditions in Virginia
Breast Cancer (8)Ovarian Cancer (7)Endometrial Cancer (7)NSCLC (7)Prostate Cancer (6)Colorectal Cancer (6)Non-Small Cell Lung Cancer (6)Advanced Solid Tumors (5)Solid Tumors (5)Advanced Solid Tumor (5)Heart Failure (4)Non-small Cell Lung Cancer (4)
NCT06728072 Phase 2
Recruiting
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Condition
Colorectal Cancer
Enrollment
97 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT06933329 Phase 2
Recruiting
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell...
Condition
Non-Small Cell Lung Cancer
Enrollment
73 pts
Location
United States, France, Spain
Sponsor
BicycleTx Limited
View Trial →
NCT05467891 Phase 2
Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurr...
Condition
Locoregional Recurrence
Enrollment
200 pts
Location
United States
Sponsor
Oana Danciu
View Trial →
NCT06310291 EARLY_Phase 1
Recruiting
VTP-1000 in Adults With Celiac Disease
Condition
Celiac Disease
Enrollment
45 pts
Location
United States
Sponsor
Barinthus Biotherapeutics
View Trial →
NCT06043817 Phase 1, Phase 2
Recruiting
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or...
Condition
Non-Small Cell Lung Cancer
Enrollment
251 pts
Location
United States, France, Germany
Sponsor
Pierre Fabre Medicament
View Trial →
NCT06112613 N/A
Recruiting
Mobile Health for Adherence in Breast Cancer Patients
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
410 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07422480 Phase 3
Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With ...
Condition
Myelodysplastic Syndrome
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
View Trial →
NCT04373317 Phase 4
Recruiting
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Condition
Parkinson's Disease Psychosis
Enrollment
358 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06657235 N/A
Recruiting
Transitional Care Program to Improve Risk Factors in Stroke Survivors
Condition
Stroke, Ischemic
Enrollment
224 pts
Location
United States
Sponsor
Syntrillo, Inc
View Trial →
NCT05790850 N/A
Recruiting
Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical C...
Condition
Bladder Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07179380 Phase 3
Recruiting
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in P...
Condition
Pulmonary Hypertension
Enrollment
344 pts
Location
United States, Argentina, Belgium
Sponsor
Insmed Incorporated
View Trial →
NCT06445946 Phase 4
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Tr...
Condition
Gestational Diabetes Mellitus
Enrollment
1,572 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT06585241 Phase 4
Recruiting
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-co...
Condition
SARS-CoV-2
Enrollment
1,144 pts
Location
United States
Sponsor
ModernaTX, Inc.
View Trial →
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT07187115 N/A
Recruiting
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping ...
Condition
Atrial Fibrillation (AF)
Enrollment
699 pts
Location
United States, Belgium, France
Sponsor
Boston Scientific Corporation
View Trial →
NCT06851559 Phase 2
Recruiting
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to ...
Condition
Eosinophilic Esophagitis
Enrollment
80 pts
Location
United States
Sponsor
Phathom Pharmaceuticals, Inc.
View Trial →
NCT05963074 Phase 2
Recruiting
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previous...
Condition
Leukemia, Lymphocytic, Chronic, B-Cell
Enrollment
320 pts
Location
United States, Canada, Czechia
Sponsor
Janssen Research & Development
View Trial →
NCT07427797 Phase 3
Recruiting
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Modera...
Condition
Moderate to Severe Glabellar Lines
Enrollment
300 pts
Location
United States, Canada
Sponsor
Ipsen
View Trial →
NCT05254743 Phase 3
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chroni...
Condition
Chronic Lymphocytic Leukemia
Enrollment
662 pts
Location
United States, Argentina, Australia
Sponsor
Loxo Oncology, Inc.
View Trial →
NCT07226258 Phase 3
Recruiting
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis K...
Condition
Osteoarthritis Knee Pain
Enrollment
150 pts
Location
United States
Sponsor
Saol Therapeutics Inc
View Trial →
NCT05683418 Phase 1
Recruiting
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Br...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
241 pts
Location
United States, Spain
Sponsor
Totus Medicines
View Trial →
NCT06895603 N/A
Recruiting
The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety...
Condition
ICU
Enrollment
75 pts
Location
United States, Germany
Sponsor
Philips Clinical & Medical Aff
View Trial →
NCT07157774 Phase 3
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With...
Condition
Elevated Lp(a)
Enrollment
10,450 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,250 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT05481879 Phase 1, Phase 2
Recruiting
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DY...
Condition
Myotonic Dystrophy Type 1 (DM1)
Enrollment
116 pts
Location
United States, Australia, France
Sponsor
Dyne Therapeutics
View Trial →
Page 7 of 10 — 250 trials total
← Prev Next →